Drawing for AXITHRA

USPTO serial 79376834

AXITHRA

Reviewed by CopyMark Law Group

Reg. 7592484Status 700Registered
Filing date
Status date
Registration date
Dec 10, 2024
Examiner
BLANE, SUZANNE
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with AXITHRA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Elizabeth A. Cominolli

Elizabeth A. Cominolli Markert & Cominolli PLLC75 S. Clinton Ave., Suite 510Anna van Buerenplein 21 ARochester, NY 14604

Goods and services

ClassDescriptionStatusFirst use
009Research laboratory analyzers for measuring, testing and analyzing blood and other bodily fluids; photonic detectors, namely, photon detectors for measuring and monitoring drug concentrations and drug effectiveness in biological samples, blood, and other bodily fluids; silicon chips; downloadable computer software relating to the medical field, namely, computer software for measuring and monitoring drug concentrations and drug effectiveness in biological samples, blood, and other bodily fluids; measuring, detecting, monitoring and controlling devices, namely, research laboratory analyzers for measuring, testing and analyzing biological samples, blood and other bodily fluids; sensors, detectors and monitoring instruments, namely, photonic sensors, photon detectors, and monitoring instruments for photonic detection and signal transmission; monitoring apparatus and instruments, namely, monitoring devices for monitoring drug concentrations and drug effectiveness in biological samples, blood and other bodily fluidsACTIVE—
010Medical instruments for therapeutic drug monitoring; photo electron spectroscopy analyzers for medical purposes; x-ray spectroscopy apparatus for medical use; patient monitoring instruments, namely, medical instruments for measuring and monitoring drug concentrations and drug effectiveness in blood and other bodily fluids; diagnostic, examination, and monitoring equipment, namely, medical apparatus for measuring and monitoring drug concentrations and drug effectiveness in blood and other bodily fluids; electronic monitoring instruments for medical use, namely, medical instruments for measuring and monitoring drug concentrations and drug effectiveness in blood and other bodily fluids; sensor apparatus for medical use in diagnosis, namely, patient sensors for measuring and monitoring drug concentrations and drug effectiveness in blood and other bodily fluids; electro-medical appliances for medical purposes, namely, medical instruments for measuring and monitoring drug concentrations and drug effectiveness in blood and other bodily fluids; medical apparatus for drug administration, namely, medical apparatus for intravenous administration of medicinesACTIVE—
042Product research and development services; pharmaceutical research and development services; medical and pharmacological research services; design and development of medical technology; design and development of medical diagnostic apparatus; design and development of medical monitoring apparatus; design and development of computer software for use with medical technologyACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 21, 2025FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
May 12, 2025XXSSGENERIC MADRID TRANSACTION SENT TO IB—
May 12, 2025XXCRGENERIC MADRID TRANSACTION CREATED—
May 1, 2025CHLDCHANGE OF OWNER RECEIVED FROM IB—
Mar 14, 2025OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Mar 10, 2025FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Feb 27, 2025OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Feb 27, 2025OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Dec 10, 2024NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Dec 10, 2024R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Oct 8, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Oct 8, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 18, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Sep 3, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 9, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 9, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 9, 2024TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 31, 2024RFNTREFUSAL PROCESSED BY IB—
Jan 11, 2024RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jan 11, 2024RFRRREFUSAL PROCESSED BY MPU—
Dec 29, 2023RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Dec 28, 2023CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 19, 2023DOCKASSIGNED TO EXAMINER—
Oct 10, 2023CORRCORRECTION FROM IB ENTERED - NO REVIEW REQUIRED—
Oct 2, 2023CRCVCORRECTION TRANSACTION RECEIVED FROM IB—
Aug 22, 2023MAFRAPPLICATION FILING RECEIPT MAILED—
Aug 18, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 17, 2023REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance